Loading...

HSCS HEARTSCIENCES INC Capital Structure Changes 8-K Filing

HRTS

HSCS

HEARTSCIENCES INC

(HSCS)

2025 8-K

Equity Awards Update

Loan Agreement Update

Compliance Restored

Financial Results Update

Equity Offerings

Equity Offerings

Financial Statements

Primary Offerings

Compensatory Arrangements o...

Management Changes

Pre-Market Approval

Equity Offerings

Equity Offerings

Voluntary Delisting

Nasdaq Compliance Issue

Financial Results

Stock Options Award

Public Offering Withdrawal

Financial Results

Annual Meeting Results

Financial Results

Note Purchase Agreement

Loan Agreement Update

Results of Operations and F...

Compliance Regained with Na...

Amendment to Form 8-K/A

Reverse Stock Split

Earnings Reports

Annual Meeting Results

Annual Meeting of Shareholders

Earnings Reports

Agreement with Mount Sinai

Compliance with Nasdaq List...

Compliance with Nasdaq List...

Loan Agreement, Warrant Iss...

Equity Distribution Agreement

Equity Distribution Agreement

License Agreements and Secu...

Earnings Report

Patent Allowance Announcement

Financial Statements

Stock Options Awarded

Press Release and Equity In...

Purchase Agreement and Regi...

Equity Issuance

Amendment to Warrants

Amendment to Loan Agreement

Equity Investment

Resignation and Appointment...

External Links:

HeartSciences Inc. filed an 8-K on November 28, 2025, reporting changes to its Equity Incentive Plan, increasing available shares to 1,250,000 and detailing stock awards to executives including 70,000 shares for CEO Andrew Simpson, with conditions for vesting tied to company performance and employment status.

AI Assistant

HEARTSCIENCES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.